01 / Authoritative or substantiated
Blacklist indicators
Formal sanctions, regulatory, enforcement or judicial information, and sufficiently substantiated internal findings where appropriate.
Flagship service
Commercial Counterparty Due Diligence Support
Review identity, representative authority, source evidence and unresolved risk indicators before progressing a commercial counterparty relationship.
Request a service assessmentTBH / COMMERCIAL COUNTERPARTY DUE DILIGENCE SUPPORTSTRUCTURE • CONTROL • PROGRESS
02 / Enhanced review
Grey-list indicators
Incomplete, disputed, circumstantial, unverified or allegation-based information requiring careful qualification.
03 / IDENTITY AND COUNTERPARTY RESEARCH
Counterparty review
Research individuals, companies, buyers, sellers, intermediaries, consultants, brokers and proposed counterparties. Supply the legal name, jurisdiction, role and relevant records. Findings should identify sources, dates, matching evidence and unresolved identity questions.
04 / TRANSACTION FAILURE FACTORS
Common reasons transactions fail
Unclear authority, incomplete KYC, unverifiable proof, inconsistent agreements, undefined fees, excessive intermediary chains, communication breakdown, non-performance, regulatory obstacles and fraud indicators. Use these indicators to identify missing evidence and assign follow-up actions. An indicator is a reason for proportionate review, not proof of wrongdoing.
05 / DEEPER SOURCE-LED REVIEW
Enhanced review
Deeper source-led work where complexity or unresolved information warrants additional review. Resolve material inconsistencies through independent source checks and appropriate professional review before proceeding. Record limitations and the decision owner.
STRUCTURE. PROTECT. PROGRESS.
Choose the next appropriate step.
DiscordPractical scope and preparation guidance
Scope and information needed
Provide the legal name, registration jurisdiction, role, authority records and the question requiring review. Identify which people or entities the evidence actually concerns.
Source hierarchy and identity uncertainty
Distinguish official warnings, substantiated findings, private reports and allegations. Record source, date, jurisdiction and matching evidence. Blacklist indicators warrant careful qualification; grey-list indicators call for further review.
Review outputs and limitations
The scoped review records findings, gaps and follow-up actions. No public live screening database or universal commodity registry is supplied here. Absence of an adverse result is not proof of safety, and disputed information is not established wrongdoing.